hmgt 400 exercise 4

profileNana21
HMGT400WEEK3EXERCISE.docx

Alesix Tieku

HMGT 400 (7980)

Professor Hossein Zare

April 05, 2019

Week 3 Exercise:

The dataset provides Herfindahl–Hirschman Index, and herfindahel index categories, please use the herf_cat variable and answer the following questions:

Note: “The Herfindahl–Hirschman Index is a commonly accepted measure of market concentration used by antitrust enforcement agencies and scholars in the field. The HHI is calculated by squaring the market share of each firm competing in the market and then summing the resulting numbers” (NASI, 2015; pp: 14-16). read more from here:

https://www.urban.org/sites/default/files/publication/50116/2000212-Addressing-Pricing-Power-in-Health-Care-Markets.pdf

For this exercise you do not need to compute the HHI, but if you have any questions, please do not hesitate to ask me, but try to learn more about this you will need that to report your findings.

Use the dataset from week1 exercise and then answer the following questions:

1. Compare the following information between hospitals located in high, moderate and low competitive markets? (table 1)

Table 3. Comparing hospital characteristics and market, 2011 and 2012

Variables

High Competitive Market

Moderate Competitive Market

Low Competitive

Market

ANOVA (results)

N

Mean

STD

N

Mean

STD

N

Mean

STD

Hospital Characteristics

Hospital beds

219

130.9178

386.1857

1332

420.5188

594.2665

1479

373.6403

562.2281

F value=6.3724

P value=0.01164

Number of paid Employee

219

499.8935

813.2644

1324

1570.1115

1954.9221

1470

1308.9686

1722.4468

F value=3.0271

P value=0.08198

Number of non-paid Employee

0

Null

Null

25

35.87832

30.50019

35

47.00928

97.11851

F value=0.3055

P value=0.5826

Internes and Residents

22

38.32182

45.60323

423

112.20558

176.11024

480

86.55375

149.89660

F value=1.9973

P value=0.1579

System Membership

219

0.4246575

0.4954233

1332

0.6073574

0.4885218

1479

0.6315078

0.4825590

F value=21.572

P value=3.553e-06

Total hospital cost

219

73687086

121326585

1332

255520655

341985822

1479

201077823

267368743

F value=0.83

P value=0.3623

Total hospital revenues

219

17.48018

1.029278

1332

18.71215

1.461939

1479

18.39917

1.627141

F value=4.4126

P value=0.03576

Hospital net benefit

219

4013058

19021599

1332

15320472

39434375

1479

13353106

41078313

F value=1.8043

P value=0.1793

Available Medicare days

219

5377.214

9993.885

1324

18983.776

20297.62

1472

16792.697

19219.182

F value=12.292

P value=0.0004616

Available Medicaid days

217

1416.413

4429.091

1317

6553.995

10676.835

1451

4812.455

8164.626

F value=0.0876

P value=0.7673

Total Hospital Discharge

219

2607.836

5065.392

1326

11100.959

11741.300

1472

9120.806

10397.483

F value=6.1548

P value=0.01316

Medicare discharge

219

1067.938

1753.820

1324

3781.610

3652.702

1472

3435.407

3623.243

F value=19.615

P value=9.81e-06

Medicaid discharge

217

309.8802

748.9359

1334

1324.1560

1961.7498

1448

1066.6464

1605.2900

F value=2.4087

P value=0.1208

Herfindahel index

219

1.963470

0.1880338

1332

1.668919

0.6663497

1479

1.697769

0.6392140

F value=9.3585

P value=0.002239

2. What are the main significant differences between hospitals in different markets? (use Anova test)

Hypothesis statement

H0: There is no significant difference between the three competitive market levels

H1: There is a significant difference between the competitive market levels

The main significant difference among the three different markets are on variables Hospital beds, System membership, total hospital revenues, Available medical days, Total hospital discharge, Medicare discharge and Herfindahel index. On these 7 variables the P values are less than the level of significance of 0.05 in all cases, therefore we reject the null hypothesis and conclude that there is a significant difference in the three market levels on these 7 variables. On the rest on the variables the P value of the Anova tests is greater than the level of significance of 0.05 hence we do not reject the null hypothesis and therefore conclude that there is no significant difference.

3. Use the density curves and compare hospitals cost and revenues between three markets.

For hospital cost as competition reduces the mean of the total hospital increases. This is evident by the decreasing frequency on figure 5.

For the hospital revenue, from the descriptive statistics it is clear high competitive have markets have the least revenue and moderate competitive markets have the greatest revenue. This has clearly been brought out by the distribution on figure 6.

4. What is the impact of being in high-competitive market on hospital revenues and cost? Do you think being in high-competitive market has positive impact on net hospital benefits? What about the number of Medicare and Medicaid discharge? Do you think hospitals in higher completive market more likely to accept more Medicare and Medicaid patients? What are the impact of other variables? Please discuss your findings in 1-2 paragraphs

(Note: to answer to the last question, please compute the ratio-medicare-discharge and ratio-medicaid-discharge first and then run 2 ttest ) high vs. moderate and high vs. low competitive market), please support your findings with box-plot

In high competitive market both the total hospital cost mean and the total hospital revenue mean are lowest compared to the other two levels of market. This implies that” a high competitive market leads to low hospital cost and subsequent low revenue. This is despite the fact that Anova test shows that total hospital cost shows there is no significant difference in the three market levels while total hospital revenue shows a significant difference.

The mean net hospital benefit in high competitive market is 4,013,058, that of moderate competitive market is 15,320,472 and in low competitive market is 13,353,106. It is very clear that net hospital benefit is lowest in high competitive market from the mean. This implies that a high competitive market does not have a positive impact on the net hospital benefit. Despite this, there is no significant difference in net hospital benefit in the three competitive market levels.

The medicare discharge is lowest at the highest competitive market level(0) and greatest at moderate competition market level (1)

The medicaid discharge is lowest at the highest competitive market level (0) and greatest at moderate competition market level (1) although the difference in moderate competitive market level (1) and low competitive level (2) is minimal.

I believe hospitals in higher competitive market are more likely to accept more Medicare and Medicaid patients due to the low mean discharges at the high competitive market which implies there should be room to accept more Medicare and Medicaid discharges